Assessment of the effects of telmisalthan and olmethaltan on inflammation and oxidative stress in patients on maintenance hemodialysis.
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2012
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Telmisartan (Primary)
- Indications Secondary hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 01 Feb 2012 Results published in Clinical and Experimental Hypertension (CEH).
- 25 Jan 2010 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 25 Jan 2010 Actual initiation date (Jan 2010) added as reported by University Hospital Medical Information Network - Japan record.